Yeah. Normally I would argue otherwise, but today management made it pretty darn clear about their stake in the GW Kaolin Project with ADN.
From the Chairman’s address to shareholders which highlights that the directors’ concern, and the presentation which slide after slide hammered away the point that our evaluation should be sitting closer to ~37cents.
Also when Andrew Woskett (managing director) was speaking he mentioned something that really stuck with me today. It was something along the lines of “we must, we will and we have to get the share price” up to a fair evaluation to return value to shareholders.
- Forums
- ASX - By Stock
- MEP
- Ann: Chairman's Address to Shareholders
Ann: Chairman's Address to Shareholders, page-28
Featured News
Add MEP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online